Cost Per Responder Analysis of Sucrofferric Oxhydroxide Versus Sevelamer Carbonate in Patients on Hemodialysis in Europe
Nov 1, 2016, 00:00 AM
10.1016/j.jval.2016.09.997
https://www.valueinhealthjournal.com/article/S1098-3015(16)32363-4/fulltext
Section Title :
Disease-Specific Studies
Section Order :
935
First Page :
A518
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)32363-4&doi=10.1016/j.jval.2016.09.997